Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

A model of guided cell self-organization for rapid and spontaneous formation of functional vessels.

Andrique L, Recher G, Alessandri K, Pujol N, Feyeux M, Bon P, Cognet L, Nassoy P, Bikfalvi A.

Sci Adv. 2019 Jun 12;5(6):eaau6562. doi: 10.1126/sciadv.aau6562. eCollection 2019 Jun.

PMID:
31206014
2.

Beyond the tumour microenvironment.

Laplane L, Duluc D, Bikfalvi A, Larmonier N, Pradeu T.

Int J Cancer. 2019 Apr 16. doi: 10.1002/ijc.32343. [Epub ahead of print] Review.

PMID:
30989643
3.

Deciphering the complex role of thrombospondin-1 in glioblastoma development.

Daubon T, Léon C, Clarke K, Andrique L, Salabert L, Darbo E, Pineau R, Guérit S, Maitre M, Dedieu S, Jeanne A, Bailly S, Feige JJ, Miletic H, Rossi M, Bello L, Falciani F, Bjerkvig R, Bikfalvi A.

Nat Commun. 2019 Mar 8;10(1):1146. doi: 10.1038/s41467-019-08480-y.

4.

[Science, truth and beliefs].

Bikfalvi A.

Med Sci (Paris). 2018 Nov;34(11):990-998. doi: 10.1051/medsci/2018233. Epub 2018 Dec 10. French.

PMID:
30526832
5.

The Multiple Layers of the Tumor Environment.

Laplane L, Duluc D, Larmonier N, Pradeu T, Bikfalvi A.

Trends Cancer. 2018 Dec;4(12):802-809. doi: 10.1016/j.trecan.2018.10.002. Epub 2018 Oct 24. Review.

PMID:
30470302
6.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW.

Angiogenesis. 2018 Aug;21(3):425-532. doi: 10.1007/s10456-018-9613-x. Review.

7.

DDR1 and DDR2 physical interaction leads to signaling interconnection but with possible distinct functions.

Croissant C, Tuariihionoa A, Bacou M, Souleyreau W, Sala M, Henriet E, Bikfalvi A, Saltel F, Auguste P.

Cell Adh Migr. 2018;12(4):324-334. doi: 10.1080/19336918.2018.1460012. Epub 2018 Jun 25.

PMID:
29616590
8.

Methods for Mapping the Extracellular and Membrane Proteome in the Avian Embryo, and Identification of Putative Vascular Targets or Endothelial Genes.

Kilarski WW, Herbert J, Bikfalvi A.

Methods Mol Biol. 2018;1722:31-56. doi: 10.1007/978-1-4939-7553-2_3.

PMID:
29264797
9.

The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors.

Boyé K, Pujol N, D Alves I, Chen YP, Daubon T, Lee YZ, Dedieu S, Constantin M, Bello L, Rossi M, Bjerkvig R, Sue SC, Bikfalvi A, Billottet C.

Nat Commun. 2017 Nov 17;8(1):1571. doi: 10.1038/s41467-017-01686-y.

10.

Oligomerization State of CXCL4 Chemokines Regulates G Protein-Coupled Receptor Activation.

Chen YP, Wu HL, Boyé K, Pan CY, Chen YC, Pujol N, Lin CW, Chiu LY, Billottet C, Alves ID, Bikfalvi A, Sue SC.

ACS Chem Biol. 2017 Nov 17;12(11):2767-2778. doi: 10.1021/acschembio.7b00704. Epub 2017 Oct 4.

PMID:
28945356
11.

Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study.

Ravaud A, Gomez-Roca C, Picat MQ, Digue L, Chevreau C, Gimbert A, Chauzit E, Sitta R, Cornelis F, Asselineau J, Aziza R, Daste A, Quemener C, Baud J, Bikfalvi A, Pedenon-Périchout D, Doussau A, Molimard M, Delord JP.

Eur J Cancer. 2017 Nov;85:39-48. doi: 10.1016/j.ejca.2017.07.031. Epub 2017 Sep 5.

PMID:
28886476
12.

Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR).

Boyé K, Billottet C, Pujol N, Alves ID, Bikfalvi A.

Sci Rep. 2017 Sep 6;7(1):10703. doi: 10.1038/s41598-017-11151-x.

13.

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas.

Dufies M, Giuliano S, Viotti J, Borchiellini D, Cooley LS, Ambrosetti D, Guyot M, Ndiaye PD, Parola J, Claren A, Schiappa R, Gal J, Frangeul A, Jacquel A, Cassuto O, Grépin R, Auberger P, Bikfalvi A, Milano G, Escudier B, Rioux-Leclercq N, Porta C, Negrier S, Chamorey E, Ferrero JM, Pagès G.

Br J Cancer. 2017 Sep 26;117(7):947-953. doi: 10.1038/bjc.2017.276. Epub 2017 Aug 29.

14.

History and conceptual developments in vascular biology and angiogenesis research: a personal view.

Bikfalvi A.

Angiogenesis. 2017 Nov;20(4):463-478. doi: 10.1007/s10456-017-9569-2. Epub 2017 Jul 24. Review.

PMID:
28741165
15.

All-in-one 3D printed microscopy chamber for multidimensional imaging, the UniverSlide.

Alessandri K, Andrique L, Feyeux M, Bikfalvi A, Nassoy P, Recher G.

Sci Rep. 2017 Feb 10;7:42378. doi: 10.1038/srep42378.

16.

Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas.

Dufies M, Giuliano S, Ambrosetti D, Claren A, Ndiaye PD, Mastri M, Moghrabi W, Cooley LS, Ettaiche M, Chamorey E, Parola J, Vial V, Lupu-Plesu M, Bernhard JC, Ravaud A, Borchiellini D, Ferrero JM, Bikfalvi A, Ebos JM, Khabar KS, Grépin R, Pagès G.

Cancer Res. 2017 Mar 1;77(5):1212-1226. doi: 10.1158/0008-5472.CAN-16-3088. Epub 2017 Jan 13.

17.

Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer.

Quemener C, Baud J, Boyé K, Dubrac A, Billottet C, Soulet F, Darlot F, Dumartin L, Sire M, Grepin R, Daubon T, Rayne F, Wodrich H, Couvelard A, Pineau R, Schilling M, Castronovo V, Sue SC, Clarke K, Lomri A, Khatib AM, Hagedorn M, Prats H, Bikfalvi A.

Cancer Res. 2016 Nov 15;76(22):6507-6519. doi: 10.1158/0008-5472.CAN-15-2864. Epub 2016 Sep 9.

18.

Computational Modelling of Metastasis Development in Renal Cell Carcinoma.

Baratchart E, Benzekry S, Bikfalvi A, Colin T, Cooley LS, Pineau R, Ribot EJ, Saut O, Souleyreau W.

PLoS Comput Biol. 2015 Nov 23;11(11):e1004626. doi: 10.1371/journal.pcbi.1004626. eCollection 2015 Nov.

19.

Glioblastoma invasion and cooption depend on IRE1α endoribonuclease activity.

Jabouille A, Delugin M, Pineau R, Dubrac A, Soulet F, Lhomond S, Pallares-Lupon N, Prats H, Bikfalvi A, Chevet E, Touriol C, Moenner M.

Oncotarget. 2015 Sep 22;6(28):24922-34. doi: 10.18632/oncotarget.4679.

20.

Practical Considerations for Omics Experiments in Biomedical Sciences.

Vaudel M, Barsnes H, Bjerkvig R, Bikfalvi A, Selheim F, Berven FS, Daubon T.

Curr Pharm Biotechnol. 2016;17(1):105-14. Review.

PMID:
26278526
21.

INHIBITION OF ERN1 SIGNALING ENZYME AFFECTS HYPOXIC REGULATION OF THE EXPRESSION OF E2F8, EPAS1, HOXC6, ATF3, TBX3 AND FOXF1 GENES IN U87 GLIOMA CELLS.

Minchenko OH, Tsymbal DO, Minchenko DO, Kovalevska OV, Karbovskyi LL, Bikfalvi A.

Ukr Biochem J. 2015 Mar-Apr;87(2):76-87.

PMID:
26255341
22.
23.

Inference of Low and High-Grade Glioma Gene Regulatory Networks Delineates the Role of Rnd3 in Establishing Multiple Hallmarks of Cancer.

Clarke K, Daubon T, Turan N, Soulet F, Mohd Zahari M, Ryan KR, Durant S, He S, Herbert J, Ankers J, Heath JK, Bjerkvig R, Bicknell R, Hotchin NA, Bikfalvi A, Falciani F.

PLoS Genet. 2015 Jul 1;11(7):e1005325. doi: 10.1371/journal.pgen.1005325. eCollection 2015 Jul.

24.

Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells.

Minchenko OH, Tsuchihara K, Minchenko DO, Bikfalvi A, Esumi H.

World J Gastroenterol. 2014 Oct 14;20(38):13705-17. doi: 10.3748/wjg.v20.i38.13705. Review.

25.

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography.

Platonova N, Miquel G, Chiu LY, Taouji S, Moroni E, Colombo G, Chevet E, Sue SC, Bikfalvi A.

PLoS One. 2014 Oct 9;9(10):e110055. doi: 10.1371/journal.pone.0110055. eCollection 2014.

26.

Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases.

Sfaxi F, Scamuffa N, Lalou C, Ma J, Metrakos P, Siegfried G, Ragg H, Bikfalvi A, Calvo F, Khatib AM.

Oncotarget. 2014 Jun 30;5(12):4195-210.

27.

VEGF modulates synaptic activity in the developing spinal cord.

Guérit S, Allain AE, Léon C, Cazenave W, Ferrara N, Branchereau P, Bikfalvi A.

Dev Neurobiol. 2014 Nov;74(11):1110-22. doi: 10.1002/dneu.22187. Epub 2014 May 24.

28.

High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor.

Auf G, Jabouille A, Delugin M, Guérit S, Pineau R, North S, Platonova N, Maitre M, Favereaux A, Vajkoczy P, Seno M, Bikfalvi A, Minchenko D, Minchenko O, Moenner M.

BMC Cancer. 2013 Dec 13;13:597. doi: 10.1186/1471-2407-13-597.

29.

Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5.

Exertier P, Javerzat S, Wang B, Franco M, Herbert J, Platonova N, Winandy M, Pujol N, Nivelles O, Ormenese S, Godard V, Becker J, Bicknell R, Pineau R, Wilting J, Bikfalvi A, Hagedorn M.

Oncotarget. 2013 Dec;4(12):2302-16.

30.

CXCR3, a double-edged sword in tumor progression and angiogenesis.

Billottet C, Quemener C, Bikfalvi A.

Biochim Biophys Acta. 2013 Dec;1836(2):287-95. doi: 10.1016/j.bbcan.2013.08.002. Epub 2013 Aug 27. Review.

PMID:
23994549
31.

Regulation of the Src kinase-associated phosphoprotein 55 homologue by the protein tyrosine phosphatase PTP-PEST in the control of cell motility.

Ayoub E, Hall A, Scott AM, Chagnon MJ, Miquel G, Hallé M, Noda M, Bikfalvi A, Tremblay ML.

J Biol Chem. 2013 Sep 6;288(36):25739-48. doi: 10.1074/jbc.M113.501007. Epub 2013 Jul 29.

32.

CXCL4L1-fibstatin cooperation inhibits tumor angiogenesis, lymphangiogenesis and metastasis.

Prats AC, Van den Berghe L, Rayssac A, Ainaoui N, Morfoisse F, Pujol F, Legonidec S, Bikfalvi A, Prats H, Pyronnet S, Garmy-Susini B.

Microvasc Res. 2013 Sep;89:25-33. doi: 10.1016/j.mvr.2013.05.005. Epub 2013 Jun 4.

33.

Altered angiogenesis in low birth weight individuals: a role for anti-angiogenic circulating factors.

Ligi I, Simoncini S, Tellier E, Grandvuillemin I, Marcelli M, Bikfalvi A, Buffat C, Dignat-George F, Anfosso F, Simeoni U.

J Matern Fetal Neonatal Med. 2014 Feb;27(3):233-8. doi: 10.3109/14767058.2013.807237. Epub 2013 Jun 20.

PMID:
23701307
34.

Mapping the extracellular and membrane proteome associated with the vasculature and the stroma in the embryo.

Soulet F, Kilarski WW, Roux-Dalvai F, Herbert JM, Sacewicz I, Mouton-Barbosa E, Bicknell R, Lalor P, Monsarrat B, Bikfalvi A.

Mol Cell Proteomics. 2013 Aug;12(8):2293-312. doi: 10.1074/mcp.M112.024075. Epub 2013 May 14.

35.

Alternative C-terminal helix orientation alters chemokine function: structure of the anti-angiogenic chemokine, CXCL4L1.

Kuo JH, Chen YP, Liu JS, Dubrac A, Quemener C, Prats H, Bikfalvi A, Wu WG, Sue SC.

J Biol Chem. 2013 May 10;288(19):13522-33. doi: 10.1074/jbc.M113.455329. Epub 2013 Mar 27.

36.

Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1.

Platonova N, Miquel G, Regenfuss B, Taouji S, Cursiefen C, Chevet E, Bikfalvi A.

Blood. 2013 Feb 14;121(7):1229-37. doi: 10.1182/blood-2012-08-450502. Epub 2012 Dec 20.

37.

The experimental renal cell carcinoma model in the chick embryo.

Fergelot P, Bernhard JC, Soulet F, Kilarski WW, Léon C, Courtois N, Deminière C, Herbert JM, Antczak P, Falciani F, Rioux-Leclercq N, Patard JJ, Ferrière JM, Ravaud A, Hagedorn M, Bikfalvi A.

Angiogenesis. 2013 Jan;16(1):181-94. doi: 10.1007/s10456-012-9311-z. Epub 2012 Oct 18.

PMID:
23076651
38.

Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis.

Larrieu-Lahargue F, Welm AL, Bouchecareilh M, Alitalo K, Li DY, Bikfalvi A, Auguste P.

PLoS One. 2012;7(6):e39540. doi: 10.1371/journal.pone.0039540. Epub 2012 Jun 25.

39.

The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression.

Bernard H, Garmy-Susini B, Ainaoui N, Van Den Berghe L, Peurichard A, Javerzat S, Bikfalvi A, Lane DP, Bourdon JC, Prats AC.

Oncogene. 2013 Apr 25;32(17):2150-60. doi: 10.1038/onc.2012.242. Epub 2012 Jun 25.

40.

Angiogenesis and invasion in cancer.

Bikfalvi A.

Handb Clin Neurol. 2012;104:35-43. doi: 10.1016/B978-0-444-52138-5.00003-7. Review. No abstract available.

PMID:
22230433
41.

Inhibition of angiogenesis and the angiogenesis/invasion shift.

Bikfalvi A, Moenner M, Javerzat S, North S, Hagedorn M.

Biochem Soc Trans. 2011 Dec;39(6):1560-4. doi: 10.1042/BST20110710. Review.

PMID:
22103487
42.

A switch toward angiostatic gene expression impairs the angiogenic properties of endothelial progenitor cells in low birth weight preterm infants.

Ligi I, Simoncini S, Tellier E, Vassallo PF, Sabatier F, Guillet B, Lamy E, Sarlon G, Quemener C, Bikfalvi A, Marcelli M, Pascal A, Dizier B, Simeoni U, Dignat-George F, Anfosso F.

Blood. 2011 Aug 11;118(6):1699-709. doi: 10.1182/blood-2010-12-325142. Epub 2011 Jun 9.

43.

A computational framework for gene regulatory network inference that combines multiple methods and datasets.

Gupta R, Stincone A, Antczak P, Durant S, Bicknell R, Bikfalvi A, Falciani F.

BMC Syst Biol. 2011 Apr 13;5:52. doi: 10.1186/1752-0509-5-52.

44.

Analysis of normal-tumour tissue interaction in tumours: prediction of prostate cancer features from the molecular profile of adjacent normal cells.

Trevino V, Tadesse MG, Vannucci M, Al-Shahrour F, Antczak P, Durant S, Bikfalvi A, Dopazo J, Campbell MJ, Falciani F.

PLoS One. 2011 Mar 30;6(3):e16492. doi: 10.1371/journal.pone.0016492.

45.

First Quantitative Imaging of Organic Fluorine within Angiogenic Tissues by Particle Induced Gamma-Ray Emission (PIGE) Analysis: First PIGE Organic Fluorine Imaging.

Lavielle S, Gionnet K, Ortega R, Devès G, Kilarski V, Wehbe K, Bikfalvi A, Déléris G.

Pharmaceutics. 2011 Mar 9;3(1):88-106. doi: 10.3390/pharmaceutics3010088.

46.

Anti-angiogenic therapy induces integrin-linked kinase 1 up-regulation in a mouse model of glioblastoma.

Verpelli C, Bertani G, Cea V, Patti M, Bikfalvi A, Bello L, Sala C.

PLoS One. 2010 Oct 29;5(10):e13710. doi: 10.1371/journal.pone.0013710.

47.

Gene signatures in wound tissue as evidenced by molecular profiling in the chick embryo model.

Soulet F, Kilarski WW, Antczak P, Herbert J, Bicknell R, Falciani F, Bikfalvi A.

BMC Genomics. 2010 Sep 14;11:495. doi: 10.1186/1471-2164-11-495.

48.

Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis.

Aidoudi S, Bikfalvi A.

Thromb Haemost. 2010 Nov;104(5):941-8. doi: 10.1160/TH10-03-0193. Epub 2010 Aug 30. Review.

PMID:
20806113
49.

Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma.

Auf G, Jabouille A, Guérit S, Pineau R, Delugin M, Bouchecareilh M, Magnin N, Favereaux A, Maitre M, Gaiser T, von Deimling A, Czabanka M, Vajkoczy P, Chevet E, Bikfalvi A, Moenner M.

Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15553-8. doi: 10.1073/pnas.0914072107. Epub 2010 Aug 11.

50.

Functional divergence between 2 chemokines is conferred by single amino acid change.

Dubrac A, Quemener C, Lacazette E, Lopez F, Zanibellato C, Wu WG, Bikfalvi A, Prats H.

Blood. 2010 Nov 25;116(22):4703-11. doi: 10.1182/blood-2010-03-274852. Epub 2010 Aug 5.

Supplemental Content

Loading ...
Support Center